ClinicalTrials.Veeva

Menu

To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds

H

Huons

Status

Unknown

Conditions

Nasolabial FOLD

Treatments

Device: Restylane® Lidocaine
Device: HARA Filler(Hyaluronic acid Filler)

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

  • Investigational Device : HARA (Hyaluronic Acid Filler)
  • Title : A Single center, Randomized, Subject & Evaluator-blind, Matched pairs, Active-controlled design Pivotal study to Evaluate the Efficacy and Safety of Injection with HARA as Compared to Restylane® Lidocaine in temporary Correction of Nasolabial folds
  • Sites and investigators : Chung-ang University Hospital(Seoul), Beom-Joon Kim, M.D, Ph.D
  • Objective : To compare the non-inferiority of HARA with Restylane® Lidocaine for evaluation of the efficacy and safety on Nasolabial Folds

Enrollment

67 estimated patients

Sex

All

Ages

19+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Those who agreed to this treatment and signed the Informed Consent Form
  2. Those who are 19 years old or more and desire to take correction of nasolabial folds
  3. Those who have an intention of refraining from other cosmetic treatment(other filler injection, laser or chemical peeling, Botox injection or wrinkle reduction) during the clinical study period
  4. Those whose Wrinkle Severity Rating Scale (WSRS) is more than 2 points at least

Exclusion criteria

  1. Those who are sensitive to lidocaine or other amide anesthesia
  2. Those who are sensitive to control device
  3. Those who are pregnant or lactating, or expect pregnancy
  4. Those who are judged by the subinvestigator to be improper for this study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

67 participants in 2 patient groups

Test Device Group(HARA filler)
Experimental group
Treatment:
Device: HARA Filler(Hyaluronic acid Filler)
Comparator Group(Restylane® Lidocaine)
Active Comparator group
Treatment:
Device: Restylane® Lidocaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems